Riskpilot← Back to searchSign inGet full accessRitvos Invest AB
ABActiveOrg 5591687701Huddungegränd 18Research and experimental development on natural sciences and engineering · NACE 7210Est. 20180 employees
Revenue 2024
SEK 690K
+28% vs 2023
EBITDA margin
-6.8%
-121% vs 2023
Equity ratio
15.9%
Financial strength
Net profit 2024
SEK -47K
+91% vs 2023
| Revenue | SEK 690K | +28% |
| EBITDA | SEK -47K | -121% |
| Net profit | SEK -47K | +91% |
| Total assets | SEK 675K | +215% |
| Equity | SEK 108K | +610% |
| Employees | 0 | — |
Legal name
Ritvos Invest AB
Org number
5591687701
Legal form
Aktiebolag
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
23 augusti 2018
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna
Company purpose
Bolaget skall bedriva konsultverksamhet inom medicin, hälsovård, terapi, bioteknik, försäljning via postorder av konsumentprodukter såsom klockor och sängkläder samt musikproduktion, äga och förvalta värdepapper och fastigheter och därmed förenlig verksamhet.
Address
Huddungegränd 18
Email
olli.ritvos@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 256 | 540 | 466 | 538 | 690 |
| Staff expenses | — | — | −52 | −0 | −217 |
| EBITDA | −29 | −1 | −3 | 227 | −47 |
| Depreciation & amort. | −0 | — | — | — | — |
| EBIT | −29 | −1 | −3 | 227 | −47 |
| Net financials | — | −0 | — | −738 | — |
| Profit before tax | 4 | −1 | −3 | −511 | −47 |
| Tax | −1 | — | — | — | — |
| Net profit | 3 | −1 | −3 | −511 | −47 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 156 | 129 | 126 | −587 | 675 |
| Equity | 130 | 129 | 126 | −21 | 108 |
| Long-term debt | 0 | — | — | — | 567 |
| Short-term debt | 26 | 0 | 0 | 0 | 0 |
| Total debt | 26 | — | — | — | 567 |
EBITDA margin
-6.8%
This company
15.8%
Market median
-143% vs market
20202024
Equity ratio
15.9%
This company
38.2%
Market median
-58% vs market
20202024
Return on equity
-43.8%
This company
18.4%
Market median
-338% vs market
20202024
Net profit margin
-6.8%
This company
8.1%
Market median
-184% vs market
20202024
Asset turnover
1.02×
This company
1.12×
Market median
+9% vs market
20202024
Debt / equity
5.27×
This company
0.62×
Market median
-750% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
MA Deputy Chief Executive Officer | Deputy Chief Executive Officer | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Chairman | 2022 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Ritvos Invest AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Mikael Anton Elias Ritvos Snellman | Deputy Chief Executive Officer | 0 companies |
| Olli Visa-Pekka Ritvos | Chairman | 0 companies |
| Marja Kristiina Ritvos | Board of Directors | 0 companies |